Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia
Download PQI pdf 1MB
Last Updated: April 1, 2023
By: Tennessee Oncology, TN | Cancer Specialists of North Florida, FL
About this PQI in Action
In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance resource for the oncology healthcare team. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action will cover the use of venetoclax (VENCLEXTA®) treatment in patients with Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL), primarily with a focus on the Venetoclax (VENCLEXTA®) Use in Chronic Lymphocytic Leukemia PQI. This article will discuss how utilizing the Venetoclax Use in Chronic Lymphocytic Leukemia PQI within medically integrated centers Tennessee Oncology (TNONC) and Cancer Specialists of North Florida (CSNF) elevates patient care.
More About This PQI in Action
Find a PQIPQI in Action
PQI in Action: Optimizing Venetoclax Treatment of Acute Myeloid Leukemia
Last Updated: December 1, 2024
PQI in Action
PQI in Action: Venetoclax (Venclexta®) for the Treatment of Acute Myeloid Leukemia
Last Updated: March 1, 2024
PQI
PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia
Last Updated: December 19, 2023
PQI
PQI: Venetoclax (Venclexta®) for the Treatment of Acute Myeloid Leukemia
Last Updated: August 30, 2023
PQI Podcast
PQI Podcast S5 Ep 10: Pharmacy Path & NCODA Venetoclax Resources
Author: GINGER BLACKMON
Last Updated: October 5, 2023